TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.

NCT01836926 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
110
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Osama Mohammad Ali ElDamshety

Collaborators